Ricky Goldwasser

Stock Analyst at Morgan Stanley

(3.81)
# 701
Out of 4,911 analysts
238
Total ratings
63.52%
Success rate
21.61%
Average return

Stocks Rated by Ricky Goldwasser

Labcorp Holdings
Jul 25, 2025
Maintains: Overweight
Price Target: $283$306
Current: $264.96
Upside: +15.49%
Centene
Jul 10, 2025
Downgrades: Equal-Weight
Price Target: $70$33
Current: $28.39
Upside: +16.24%
UnitedHealth Group
May 14, 2025
Maintains: Overweight
Price Target: $563$374
Current: $281.06
Upside: +33.07%
Doximity
Apr 24, 2025
Maintains: Equal-Weight
Price Target: $71$60
Current: $60.77
Upside: -1.27%
Charles River Laboratories International
Feb 5, 2025
Maintains: Equal-Weight
Price Target: $220$184
Current: $176.93
Upside: +4.00%
LifeStance Health Group
Apr 22, 2024
Reiterates: Overweight
Price Target: $10
Current: $4.14
Upside: +141.55%
GoodRx Holdings
Nov 10, 2023
Maintains: Equal-Weight
Price Target: $8$5.5
Current: $5.00
Upside: +10.00%
Oscar Health
Aug 30, 2023
Maintains: Equal-Weight
Price Target: $5$7.5
Current: $14.45
Upside: -48.10%
Alignment Healthcare
Aug 30, 2023
Maintains: Overweight
Price Target: $19$12
Current: $11.76
Upside: +2.04%
Quest Diagnostics
Aug 3, 2023
Reiterates: Equal-Weight
Price Target: $145
Current: $168.55
Upside: -13.97%
Reiterates: Overweight
Price Target: $365
Current: $165.02
Upside: +121.19%
Maintains: Overweight
Price Target: $403$420
Current: $711.82
Upside: -41.00%
Maintains: Overweight
Price Target: $140$120
Current: $8.96
Upside: +1,239.29%
Maintains: Overweight
Price Target: $549$620
Current: $237.98
Upside: +160.53%
Maintains: Equal-Weight
Price Target: $485$500
Current: $289.10
Upside: +72.95%
Maintains: Overweight
Price Target: $127$124
Current: $60.70
Upside: +104.28%
Maintains: Overweight
Price Target: $296$318
Current: $296.37
Upside: +7.30%
Maintains: Overweight
Price Target: $74$70
Current: $157.14
Upside: -55.45%
Maintains: Underweight
Price Target: $43$39
Current: $11.61
Upside: +235.92%
Maintains: Overweight
Price Target: $182$195
Current: $199.17
Upside: -2.09%